One year follow up analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis.

Authors	Camille V Edwards, Divaya Bhutani, Markus Mapara, Jai Radhakrishnan, Sofia Shames, Mathew S Maurer, Siyang Leng, Jonathan S Wall, Alan Solomon, Andrew Eisenberger, Suzanne Lentzsch
Journal	Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis (Amyloid) 2019 Vol. 26 Issue sup1 Pg. 115-116 ISSN: 1744-2818 [Electronic] England
PMID	31343323 (Publication Type: Clinical Trial, Phase I, Journal Article, Multicenter Study)
Chemical References	Antibodies, Monoclonal
Topics	Animals Antibodies, Monoclonal (administration & dosage, adverse effects) Female Humans Immunoglobulin Light-chain Amyloidosis (drug therapy) Male Mice

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!